CorMedix (CRMD) Deferred Taxes (2019 - 2025)

CorMedix's (CRMD) quarterly Deferred Taxes came in at $33.9 million in Q4 2025, up 156.79% quarter-over-quarter from -$59.7 million in Q3 2025.

CorMedix (CRMD) Deferred Taxes (2019 - 2025) Analysis & Trends

CorMedix has disclosed Deferred Taxes across 3 years of filings, most recently posting $33.9 million for Q4 2025.

Deferred Taxes for Q4 2025 came in at $33.9 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was -$25.8 million (changed N/A YoY), and the FY2025 annual result was -$25.8 million, changed N/A from the prior year.
Deferred Taxes came in at $33.9 million for Q4 2025 at CorMedix, up from -$59.7 million in the prior quarter.
In the past five years, Deferred Taxes ranged from a high of $33.9 million in Q4 2025 to a low of -$59.7 million in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Deferred Taxes (Qtr)
1	Alterity Therapeutics	762,369.55 Bn	762,369.51 Bn	-	-
2	Belite Bio	55,096.00 Bn	55,096.00 Bn	-	-
3	Quantum Biopharma	17,755.80 Bn	17,755.79 Bn	-	-
4	Legend Biotech	3,486.00 Bn	3,485.71 Bn	242.10 Mn	-
5	Akari Therapeutics	1,737.42 Bn	1,737.41 Bn	-	-859,000.00
6	Evaxion A	1,551.28 Bn	1,551.26 Bn	-	-
7	Psyence Biomedical	227.32 Bn	227.31 Bn	-	-
8	Vertex Pharmaceuticals	110.84 Bn	103.59 Bn	2.59 Bn	-65.30 Mn
9	Abivax	91.71 Bn	91.71 Bn	-	-
10	CorMedix	631,378.03	-154.57 Mn	107.31 Mn	33.90 Mn

Download Data